These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The treatment of left-sided cardiac decompensation, hypertensive crisis and acute heart infarct with sodium nitroprusside]. Durrer JD Ned Tijdschr Geneeskd; 1987 Aug; 131(35):1512-5. PubMed ID: 3670425 [No Abstract] [Full Text] [Related]
5. [Vasodilator treatment of chronic heart failure]. Froer KL; Hall D; Goppel L; Rudolph W Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1117-9. PubMed ID: 1029939 [No Abstract] [Full Text] [Related]
6. Comparison of ketanserin and sodium nitroprusside in patients with severe ARDS. Radermacher P; Huet Y; Pluskwa F; Herigault R; Mal H; Teisseire B; Lemaire F Anesthesiology; 1988 Jan; 68(1):152-7. PubMed ID: 3337372 [No Abstract] [Full Text] [Related]
7. Letter: Nitroprusside and cyanide. Smith RP; Kruszyna H Br J Anaesth; 1976 Apr; 48(4):396. PubMed ID: 1276011 [No Abstract] [Full Text] [Related]
8. Place of vasoactive agents in the treatment of acute circulatory failure. Vincent JL Resuscitation; 1984 Mar; 11(3-4):175-82. PubMed ID: 6326221 [TBL] [Abstract][Full Text] [Related]
9. Nitroprusside therapy in post-open heart hypertensives. A ritual tryst with cyanide death? Sarvotham SS Chest; 1987 May; 91(5):796. PubMed ID: 3568793 [No Abstract] [Full Text] [Related]
10. [Therapeutic properties of sodium nitroprusside]. Stefanov G Vutr Boles; 1980; 19(2):11-4. PubMed ID: 6992455 [No Abstract] [Full Text] [Related]
11. [Area of the ischemic lesion in acute myocardial infarct: critical review of the use of vasodilator agents]. Permutti B; Costa PP; Fernandes P; Locatelli C Boll Soc Ital Cardiol; 1980; 25(7):803-5. PubMed ID: 7272077 [No Abstract] [Full Text] [Related]
12. [The use of peripheral vasodilators in the immediate postoperative period following cardiac surgery: comparative study of the effects of dianhydrosorbitol dinitrate and sodium nitroprussate]. Fortuna AB; Wada L; Lima CE; Baccarin V; Oliveira AA Arq Bras Cardiol; 1981 Oct; 37(4):335-9. PubMed ID: 6926957 [No Abstract] [Full Text] [Related]
13. [Clinical use of sodium nitroprusside]. Trojanowski T; Szczerbo-Trojanowska M Pol Tyg Lek; 1981 Feb; 36(6):227-30. PubMed ID: 7027214 [No Abstract] [Full Text] [Related]
14. Use of sodium nitroprusside in neonates: efficacy and safety. Benitz WE; Malachowski N; Cohen RS; Stevenson DK; Ariagno RL; Sunshine P J Pediatr; 1985 Jan; 106(1):102-10. PubMed ID: 3917495 [TBL] [Abstract][Full Text] [Related]
15. Sodium nitroprusside and RDS--primum non nocere. Turmen T; Davis JM; Aranda JV Arch Dis Child; 1980 Jan; 55(1):82-3. PubMed ID: 7377829 [No Abstract] [Full Text] [Related]
16. [Cardiovascular effects of sodium pentacyanonitrosylferrate(III) (sodium nitroprusside) in experimental coronary occlusion in the minipig]. Modersohn D; Urbaszek W; Günther K; Pankau H; Gmyrek G Pharmazie; 1977 Jun; 32(6):356-7. PubMed ID: 896943 [No Abstract] [Full Text] [Related]
17. Blood cyanide produced by long-term therapy with sodium nitroprusside. Schulz V Br J Anaesth; 1986 Feb; 58(2):247-8. PubMed ID: 3942680 [No Abstract] [Full Text] [Related]
18. Rationale of vasoexcitor and vasodilator drug therapy in shock. Hershey SG Proc Inst Med Chic; 1966 May; 26(3):51. PubMed ID: 5936507 [No Abstract] [Full Text] [Related]
20. [Effect of sodium nitroprusside on central hemodynamics in healthy subjects and in a state of acute myocardial infarction]. Aleev LS; Patskina SA; Lissova OI; Kochetenko TE; Beregovskiĭ BA Fiziol Zh (1978); 1986; 32(1):75-81. PubMed ID: 3956787 [No Abstract] [Full Text] [Related] [Next] [New Search]